SMI News

10.310,00 +0,39% +40,00
19:23:58 Uhr DB Indikation Indizes | Mehr Kurse »
WKN: 969000
ISIN: CH0009980894
Typ: Index

Ad-hocs

  
01.11.19 Novartis Cosentyx® shows encouraging results versus Humira®* from first-​of-its-kind head-​to-head trial in psoriatic arthritis GlobeNewswire
30.10.19 Novartis announces AVXS-101 intrathecal study update GlobeNewswire
22.10.19 Novartis delivered another strong quarter with double digit sales growth and core1 margin expansion; 2019 sales and profit guidance raised; Beovu launched in US GlobeNewswire
22.10.19 Novartis verzeichnet ein weiteres starkes Quartal mit zweistelligem Umsatz-​wachstum und höherer Kerngewinnmarge1; Umsatz- und Gewinnerwartung für 2019 angehoben; US-​Einführung von Beovu GlobeNewswire
17.10.19 Nestlé announces changes to its waters business, establishes Group Strategy and Business Development function GlobeNewswire
17.10.19 Nestlé reports nine-​month sales for 2019 GlobeNewswire
02.10.19 Novartis positive 52-week PREVENT data confirm Cosentyx® efficacy in addressing entire axSpA spectrum GlobeNewswire
17.09.19 Novartis Cosentyx® positive 16-week PREVENT results advance potential new indication for patients with axial spondyloarthritis GlobeNewswire
30.08.19 Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-​to-head Phase III multiple sclerosis studies GlobeNewswire
05.11.18 Novartis R&D update highlights industry leading development pipeline including potential blockbusters and advanced therapy platforms GlobeNewswire
10.10.18 Novartis announces new data from the first direct head-​to-head trial to demonstrate superior efficacy of Gilenya® over Copaxone® in patients with relapsing remitting multiple sclerosis GlobeNewswire
20.09.18 Nestlé to sharpen its Nutrition, Health and Wellness strategic focus, will explore strategic options for Nestlé Skin Health GlobeNewswire
17.09.18 Nestlé agrees to sell Gerber Life Insurance Co. to Western & Southern Financial Group GlobeNewswire
11.09.18 Alcon bestätigt vor dem vorgeschlagenen Spin-off von Novartis das Engagement in der Schweiz GlobeNewswire
11.09.18 Alcon confirms commitment to Switzerland ahead of proposed spinoff from Novartis GlobeNewswire
29.08.18 Alcon announces voluntary global market withdrawal of CyPass Micro-​Stent for surgical glaucoma GlobeNewswire
28.08.18 Nestlé and Starbucks close deal for the perpetual global license of Starbucks Consumer Packaged Goods and Foodservice products GlobeNewswire
27.08.18 Novartis erhält die Zulassung für seine CAR-​T-Zell-Therapie Kymriah® (Tisagenlecleucel) von der Europäischen Kommission GlobeNewswire
27.08.18 Novartis receives European Commission approval of its CAR-T cell therapy, Kymriah® (tisagenlecleucel) GlobeNewswire
25.08.18 Novartis announces new data that show Entresto® (sacubitril/valsartan) can be initiated early & safely in hospitalized patients after an acute heart failure episode GlobeNewswire
26.07.18 Nestlé reports half-year results for 2018 GlobeNewswire
23.07.18 Novartis renews drug donation of Egaten® (triclabendazole) until 2022, reaffirming its commitment to the fight against liver fluke GlobeNewswire
19.07.18 Novartis demonstrates commitment to lead immuno-​dermatology by in-​licensing IL-17C compound for atopic dermatitis GlobeNewswire
02.07.18 Nestlé Outlines Value Creation Progress GlobeNewswire
16.05.18 Novartis kündigt Veränderungen in der Geschäftsleitung an GlobeNewswire
16.05.18 Novartis announces changes to the Executive Committee GlobeNewswire
18.04.18 Sandoz signs agreement with Pear Therapeutics to develop and commercialize prescription digital therapeutics for patients with substance use disorder and opioid use disorders GlobeNewswire
16.04.18 Novartis announces new analysis demonstrating Entresto helped preserve kidney function in patients with chronic heart failure, especially those with diabetes GlobeNewswire
27.03.18 Novartis verkauft Beteiligung an Consumer-​Healthcare-Joint-Venture für USD 13 Milliarden an GSK, um sich auf strategische Prioritäten zu konzentrieren GlobeNewswire
27.03.18 Novartis to sell stake in consumer healthcare joint venture to GSK for USD13.0 billion to focus on strategic priorities GlobeNewswire
12.03.18 Novartis kündigt Veränderungen in der Geschäftsleitung zur Unterstützung strategischer Prioritäten an GlobeNewswire
12.03.18 Novartis announces changes to the Executive Committee to support strategic priorities GlobeNewswire
08.02.18 Novartis receives FDA approval for Cosentyx® label update to include moderate-​to-severe scalp psoriasis GlobeNewswire
24.01.18 Novartis erzielt 2017 eine gute operative Performance sowie wegweisende Innovationen und ist gut gerüstet für die nächste Wachstumsphase GlobeNewswire
24.01.18 Novartis delivered good operational performance and landmark innovation in 2017, entering our next growth phase GlobeNewswire
16.01.18 SIKA ERWIRBT MEHRHEITSBETEILIGUNG AN FÜHRENDEM ITALIENISCHEN HERSTELLER VON ABDICHTUNGSSYSTEMEN FÜR DÄCHER UND BAUWERKE GlobeNewswire
16.01.18 SIKA ACQUIRES MAJORITY STAKE IN LEADING MANUFACTURER OF ROOFING AND WATERPROOFING SYSTEMS IN ITALY GlobeNewswire
16.01.18 Sandoz regulatory submission for proposed biosimilar adalimumab accepted by FDA GlobeNewswire
15.12.17 Novartis gibt Rücktritt des Onkologie-​Chefs bekannt GlobeNewswire
15.12.17 Novartis announces Oncology head to retire GlobeNewswire
13.12.17 SIKA STÄRKT MARKTPOSITION IN MEXIKO IN ROOFING UND WATERPROOFING GlobeNewswire
13.12.17 SIKA STRENGTHENS ITS MARKET POSITION IN ROOFING AND WATERPROOFING IN MEXICO GlobeNewswire
24.10.17 Novartis steigert im dritten Quartal Umsatz und Gewinn in allen Divisionen GlobeNewswire
24.10.17 Novartis delivered growth on top and bottom line in all divisions in Q3 GlobeNewswire
05.09.17 SIKA ÜBERNIMMT FÜHRENDEN HERSTELLER VON ABDICHTUNGSSYSTEMEN UND MÖRTELN IN DER TSCHECHISCHEN REPUBLIK GlobeNewswire
05.09.17 SIKA ACQUIRES LEADING MANUFACTURER OF WATERPROOFING SYSTEMS AND MORTARS IN THE CZECH REPUBLIC GlobeNewswire
24.08.17 SIKA ÜBERNIMMT FÜHRENDEN TÜRKISCHEN HERSTELLER VON DICHT- UND KLEBSTOFFEN GlobeNewswire
24.08.17 SIKA ACQUIRES LEADING TURKISH MANUFACTURER OF SEALANTS AND ADHESIVES GlobeNewswire
27.07.17 Nestlé reports half-year results for 2017 GlobeNewswire
18.07.17 Die Ergebnisse im zweiten Quartal bestätigen die Jahresprognosen - starke Forschungs- und Entwicklungsresultate untermauern das Potenzial einiger hoch innovativer Produkte GlobeNewswire

Newssuche

  

Videos

  
15:33 Uhr 0,00%
JD.com, Baozun, Sea, Grubhub, Amazon, Microsoft, Nvidia, Nike, Aurora Cannabis, Lyft - US-Markt